Cardiovascular Benefits of Once-a-Week GLP-1 RA Option for T2DM
Free
Log In
Overview
The discussion will covers several aspects of GLP-1 RA therapy including comparison to other first injectable therapies for T2DM, safety and efficacy of once-a-week GLP-1 RA.
This Activity for
- Resident / Fellow
- Physician
What I will learn?
Understand increased cardiovascular Risks with Type 2 Diabetes patients.
Understand different cardiovascular trials design and patient population distribution.
Understand the difference between primary and secondary CV protection.
Understand the results of recent CV trials for Once-weekly dulaglutide and its implications on T2D patients.
About Organizer
- Virtual Medical Academy
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
| Cardiovascular Benefits of Once-a-Week GLP-1 RA Option for T2DM Certificate | Certificate | Free |
VAT 15% Included